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Background: Many respiratory viruses disproportionately impact the elderly. Likewise, advanced age correlated
with more adverse disease outcomes following severe acute respiratory syndrome coronavirus (SARS-CoV) infection
in humans. We used an aged African green monkey SARS-CoV infection model to better understand age-related
mechanisms of increased susceptibility to viral respiratory infections. Nonhuman primates are critical translational
models for such research given their similarities to humans in immune-ageing as well as lung structure.
Results: Significant age- and infection-dependent differences were observed in both systemic and mucosal
immune compartments. Peripheral lymphocytes, specifically CD8 T and B cells were significantly lower in aged
monkeys pre- and post- SARS-CoV infection, while neutrophil and monocyte numbers were not impacted by age
or infection status. Serum proinflammatory cytokines were similar in both age groups, whereas significantly lower
levels of IL-1beta, IL-18, IL-6, IL-12 and IL-15 were detected in the lungs of SARS-CoV-infected aged monkeys at
either 5 or 10 days post infection. Total lung leukocyte numbers and relative frequency of CD8 T cells, B cells,
macrophages and dendritic cells were greatly reduced in the aged host during SARS-CoV infection, despite high
levels of chemoattractants for many of these cells in the aged lung. Dendritic cells and monocytes/macrophages
showed age-dependent differences in activation and chemokine receptor profiles, while the CD8 T cell and B cell
responses were significantly reduced in the aged host. In examination of viral titers, significantly higher levels of
SARS-CoV were detected in the nasal swabs early, at day 1 post infection, in aged as compared to juvenile monkeys,
but virus levels were only slightly higher in aged animals by day 3. Although there was a trend of higher titers in
respiratory tissues at day 5 post infection, this did not reach statistical significance and virus was cleared from all
animals by day 10, regardless of age.
Conclusions: This study provides unique insight into how several parameters of the systemic and mucosal immune
response to SARS-CoV infection are significantly modulated by age. These immune differences may contribute to
deficient immune function and the observed trend of higher SARS-CoV replication in aged nonhuman primates.* Correspondence: Kharrod@LRRI.org
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Viral respiratory infections remain a predominant cause
of morbidity and mortality in aged adults. The elderly
have heightened susceptibility to infection, an increased
risk of developing severe viral-induced pulmonary dis-
ease and have slower recovery rates [1]. Several physio-
logical parameters are thought to contribute to the poor
outcomes of infectious disease in the elderly population,
including the aging immune as well as respiratory sys-
tem. Almost all components of the immune system have
been shown to undergo age-associated restructuring that
greatly impacts immune function [2-5]. The decline in
immune function with age also results in reduced vac-
cine efficacy, further enhancing susceptibility to infec-
tion in the elderly [6-8].
Age-associated alterations in the mucosal immune sys-
tem are thought to occur at distinct times and in a dis-
tinct manner relative to systemic immunity [9]. Data
suggests that immunosenescence may occur earlier in
the mucosa than the systemic immune system with a
dramatic shift, with age, in the proportion of distinct T
cell subsets and a decrease in total B lymphocytes [3,10].
Advanced age has also been associated with a reduction
in antigen-specific IgA, an important protective antibody
predominantly localized to the mucosa [9]. In addition
to the immunological remodeling as a function of age,
there are also major alterations in respiratory physiology.
The aging lung has been shown to undergo structural
changes which include a loss in static recoil forces, a
stiffening of the chest cavity and diminished alveolar sur-
face area, ultimately resulting in reduced vital capacity
[11-13]. In addition, respiratory muscle strength consist-
ently declines with age making it more difficult for an
elderly person to breath even when not suffering from a
respiratory infection.
The limitations of the aged immune and respiratory
systems likely contributed to the increased mortality ob-
served in elderly patients (>60 years old) with severe
acute respiratory syndrome coronavirus (SARS-CoV).
The SARS-CoV epidemic in 2002–2003 resulted in over
8000 human infections with an estimated 10% mortality
rate [14]. Advanced age and comorbidities were signifi-
cantly associated with increased risk of SARS-CoV re-
lated death, due to acute respiratory distress syndrome
[15-18].
It is well appreciated that pulmonary damage in
SARS-CoV infection is caused by direct viral effects as
well as immunopathological factors [15], however the
pathogenic mechanisms in the vulnerable aged popula-
tions remain poorly defined. Several aged animal models
of SARS-CoV infection have been established to evaluate
the response and elucidate mechanisms for increased
SARS-CoV pathogenicity in the aged host. Recombinant
infectious clones and mouse passaged isolates of SARS-CoV show increased severity of disease and lethality in
aged as compared to young mice [19-21]. Interestingly,
the aged and young hosts show similar levels of SARS-
CoV replication in most experimental infections [22].
Thus the increased acute lung injury in SARS-CoV-
infected aged animals is thought to be related to the
over exuberant immune responses and not heightened
viral-mediated damage. However, many aspects of the
elderly immune response and how it may differ from the
young adult are still unclear. Furthermore, our study
represents one of only two SARS-CoV infection studies
in aged nonhuman primates as almost all aged SARS-
CoV experiments to date have been conducted in mouse
models with mouse-adapted viral strains. Although mur-
ine models are often advantageous and informative, non-
human primates may be better suited for studying the
aging immune and respiratory systems. Unlike mice,
nonhuman primates show a high level of genetic hom-
ology to humans, are not inbred, have longer life spans
and their lungs are more structurally similar to humans
than other laboratory animals [23]. Importantly, studies
have shown that nonhuman primates undergo immune
senescence similar to what has been described for
humans [24,25]. The aim of this study was to determine
how the peripheral and mucosal immune responses to
SARS-CoV infection compare in the aged and juvenile
nonhuman primate host and to determine how this may
impact viral replication levels. We report that SARS-
CoV virus titers were significantly higher in the nasal
cavity of aged monkeys at day 1 post infection but, by
day 3, the difference in titers between age groups was
negligible. Although SARS-CoV virus levels were similar
in aged and juvenile monkeys at later time points post
infection there were significant age-dependent differ-
ences in systemic and mucosal immune responses to
SARS-CoV.
Results
SARS-CoV infection and clinical features in juvenile and
aged monkeys
To evaluate the impact of advanced age on severity of
SARS-CoV infection, aged and juvenile African green
monkeys were inoculated intranasally with 107 plaque-
forming units (PFU) SARS-CoV HKU-39849 strain or
mock-infected with sacrifice at 5 or 10 days post infection
(d.p.i.). Aged animals were roughly equivalent to 50 year
old humans (n = 5 each time point post infection, n = 2 for
mock-infected) [26,27] while juvenile animals represented
6–12 year olds (n = 6 for all juvenile groups). Some of the
virology, pathology and immunology data for the juvenile
animals have been previously reported [28] but are included
here for age-related comparisons. In examination of clinical
features, all animals showed a slight initial decrease in body
weight with SARS-CoV inoculation that rebounded by 3
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post infection but not age was a significant source of vari-
ation for the fold change in body weight. Body temperature
however, fluctuated throughout the infection time course
and was significantly affected by age but not infection
(Figure 1B; 2-way ANOVA for age and d.p.i.). SARS-CoV
titers were measured in nasal swabs and in several respira-
tory tissues by plaque assays. Replicating virus was recov-
ered from nasal swabs in 7 of the 10 aged animals at 1 d.p.i.,
in contrast to only one juvenile animal with detectable
virus at this early time point (Figure 1C; 2-way ANOVA
for age and d.p.i.). Day 1 was the only time point in
which SARS-CoV replication was significantly different;
by 3 d.p.i., virus levels were only slightly higher in aged
animals and titers remained similar in both age groups
out to day 5. No significant age-dependent differences
in SARS-CoV levels were observed in standardized col-
lected respiratory tissues at 5 d.p.i. (Figure 1D; 1-way
ANOVA for age). However, the levels of virus tended to
be higher in all tissues from the aged as compared toFigure 1 Comparison of clinical features and replication levels follow
were weighed throughout the infection time course and mean values (+/−
body weight. (B) Body temperature was measured with an implanted subc
(+/− SE) are plotted in degrees Fahrenheit for aged and juvenile monkeys
longitudinally over the infection time course in nasal swabs by plaque-form
swab (+/−SE) are graphed on a log scale. Day 0–5 post infection for aged
animals, day 10 n = 6. (D) SARS-CoV replication was also evaluated at 5 day
cranial trachea sample (TrCr), caudal trachea sample (TrCd), and proximal (C
lung lobe. All tissues were collected in a standardized manner. Bar graphs
are plotted on a log scale. Aged n = 5, juvenile n = 6 for each tissue. *p < 0
infection (d.p.i) as indicated in each graph.the juvenile animals, except in the proximal portion of
the right caudal lung lobe. No virus was detected in any
sample collected from either age group at 10 d.p.i.
Comparison of lung lesions in the aged and juvenile host
following SARS-CoV infection
To determine if advanced age correlated with increased
severity of lung pathology, a comprehensive histological
analysis of the respiratory tract following SARS-CoV in-
fection was conducted in aged and juvenile animals. At
5 d.p.i. the SARS-CoV-induced histologic changes in the
lung were higher in incidence in aged compared to ju-
venile monkeys (Table 1). These changes included peri-
vascular cuffing with inflammatory cells, alveolitis and
interstitial pneumonia. However, venous thrombosis was
observed in 17-18% of the juvenile animals at both 5 and
10 d.p.i. whereas no venous thrombosis was detected in
any aged animal at either time point. The severity of
lung pathology was only slightly higher in aged as com-
pared to juvenile animals at 5 d.p.i., and by 10 d.p.i.,ing SARS-CoV-infection of aged and juvenile monkeys. (A) Animals
standard error (SE)) are graphed as the fold change over pre-infection
utaneous temperature microchip transponder. Average daily values
throughout SARS-CoV infection. (C) Viral titers were assessed
ing assays. The average plaque-forming units (PFU) per ml per nasal
animals n = 10, day 10 n = 5. Day 0–5 post infection n = 12, for juvenile
s post infection in several respiratory tract tissues including the nose,
dProx), middle (CdMid) and distal (CdDist) portions of the right caudal
of the mean (+/−SE) values of plaque-forming units per gram tissue
.05, **p < 0.01, ***p < 0.0005 by 2-way ANOVA for age or time post
Table 1 Comparison of SARS-CoV induced histologic changes in the lungs of aged and juvenile monkeys
Value
Group No. of animals Gradea Venous thrombosis Perivascular cuffing Alveolitis Interstitial pneumonia
Aged 5 d.p.i. 5 Severity 0 1.8 1.2 0.4
Incidence 0% 100% 80% 40%
Juvenile 5 d.p.i. 11 Severity 0.27 1.2 1 0.45
Incidence 18% 82% 73% 27%
Aged 10 d.p.i. 5 Severity 0 1.6 1.4 0.2
Incidence 0% 100% 80% 20%
Juvenile 10 d.p.i. 6 Severity 0.33 1.7 1.3 1.5
Incidence 17% 100% 100% 83%
Aged mock 3 Severity 0 0.33 0 0
Incidence 0% 33% 0% 0%
Juvenile mock 2 Severity 0 0 0 0
Incidence 0% 0% 0% 0%
aSeverity is the average grade for the group (0 = normal, 1 = minimal, 2 = mild, 3 =moderate, 4 = marked); incidence is the percentage of the group affected.
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for most of the histologic changes. A marked increase
in the incidence of interstitial pneumonia was observed
in juvenile but not aged monkeys at 10 d.p.i. (83% in
juvenile versus only 20% in aged). Taken together, the
histologic changes associated with SARS-CoV-induced
interstitial pneumonia were slightly lower in incidence
and severity in the aged compared to juvenile host.
Systemic and mucosal SARS-CoV-induced inflammatory
responses differ in aged compared to juvenile monkeys
To determine if there were age-specific differences in
immune activation following SARS-CoV infection, sys-
temic inflammatory responses were compared in aged
and juvenile animals. Peripheral blood draws prior to
and at days 1, 5 and 10 were used to monitor circulating
immune cell and cytokine profiles. The total white blood
cell counts for aged monkeys were lower than their ju-
venile counterparts at pre- and post SARS-CoV infec-
tion time points (Figure 2A; 2-way ANOVA for age and
d.p.i.). In examination of specific leukocyte populations,
neutrophil and monocyte numbers significantly varied
with SARS-CoV infection but were unaffected by age
(Figure 2B-C; 2-way ANOVA for age and d.p.i.). In
contrast, age was a significant source of variation for
lymphocyte numbers with reduced CD8 T cells and
B cells in the peripheral blood of aged compared to
juvenile animals (Figure 2D-F; 2-way ANOVA for
age and d.p.i.).
The serum cytokine profile during SARS-CoV infec-
tion in aged and juvenile monkeys was defined using
bead-based protein arrays focusing on inflammatory cy-
tokines and chemokines associated with antiviral re-
sponses (Table 2). In comparing the aged and juvenile
animals, the levels of IL-12 and IFN-gamma were similarbut had a trend of being higher in the aged monkeys
whereas CCL2 was higher in juveniles, although not
reaching statistical significance (2-way ANOVA for age
and d.p.i.). IL-1 receptor agonist at baseline and CCL3
levels at day 10 were significantly elevated in the serum
of aged animals over their juvenile counterparts (2-way
ANOVA for age and d.p.i. with Bonferroni post-tests).
As expected with an experiment using non-inbred ani-
mals the variation for serum cytokines was relatively
high, particularly for the aged animals which is consist-
ent with other previously published aged nonhuman pri-
mate studies [5,25].
To determine how mucosal cytokines in SARS-CoV
infection compared to systemic responses and how age
may impact mucosal cytokine expression; the inflamma-
tory protein profile was evaluated by bead-based arrays
in standardized-collected lung tissue from the proximal
portion of the right caudal lobe. The focus was on in-
flammatory cytokines thought to play a role in antiviral
immunity. In contrast to the higher cytokine trend in
the serum of aged animals, cytokines in the lung were
often lower in aged as compared to the juvenile mon-
keys. Proinflammatory cytokines IL-1beta and IL-6 were
significantly lower in aged as compared to juvenile
animals at 5 and 10 d.p.i. respectively (Figure 3A-B;
unpaired student T-test). Aged monkeys showed signifi-
cantly lower levels of IL-12 at day 5 and lower IL-15 and
IL-18 at 10 d.p.i. as compared to juveniles (Figures 3C-E;
unpaired student T-test). There was also a trend of de-
creased IL-21 levels in the lungs of aged versus juvenile
monkeys although not reaching statistical significance
(Figures 3F). Unlike the juvenile animals, interferon-
gamma was below the level of detection in aged lung
samples (data not shown). In general, cytokines tended
to increase with SARS-CoV infection in juvenile
Figure 2 Differences in peripheral blood cell populations in the aged and juvenile host following SARS-CoV infection. Peripheral blood
was collected prior to and at 5 or 10 days post SARS-CoV infection while animals were under sedation. Complete white blood cell counts and cell
differentials were assessed by the Lovelace Clinical Laboratory Staff. The number of cells × 10^3 per microliter (μl) blood are graphed for (A)
white blood cells (WBC), (B) neutrophils, (C) monocytes, and (D) lymphocytes. (E-F) The number of CD8 T cells and B cells per microliter blood
was calculated based on flow cytometric frequencies and total lymphocyte numbers. The gating strategy is depicted in Additional file 1: Figure S1.
Graphs represent average values (+/−SE). *p < 0.05, ***p < 0.0005, ****p < 0.0001 in 2-way ANOVA comparing age and time post infection
(d.p.i.) as indicated in the graphs.
Clay et al. Immunity & Ageing 2014, 11:4 Page 5 of 16
http://www.immunityageing.com/content/11/1/4monkeys whereas levels in the aged group showed no
infection-induced increase.
Age-specific differences in lung chemokine profiles
during SARS-CoV infection
Chemokines play a critical role in coordinating the mi-
gration of leukocytes into and out of the lung to trigger
effective immune responses against viral pathogens
[29,30]. The chemokine milieu in the lungs following
SARS-CoV infection was evaluated in aged and juvenile
animals by targeted protein arrays. Unlike data forTable 2 Cytokines and chemokines in serum of SARS-CoV infe
Concen
Cytokine or chemokine Day 1
Juvenile Aged Juvenile
IL-1 ra 1.7 ± 1.3 12.0 + 3.1 59 ± 3.6
IL-8 156.0 ± 66.6 198.5 ± 81.4 200.2 ± 180
IL-12 34.1 ± 6.8 66.4 ± 15.0 37.5 ± 14.
IL-15 2.2 ± 0.3 1.4 ± 0.3 3.9 ± 0.7
IL-23 34.1 ± 6.8 58.1 ± 15.4 37.5 ± 14.
IFN-y 0.7 ± 0.3 1.1 ± 0.3 1.6 ± 0.9
CCL2 1657.5 ± 129.5 1631.0 ± 463.9 3279.1 ± 61
CCL3 2.6 ± 0.7 9.4 ± 2.3 2.1 ± 1.2
Values represent picograms +/- standard error. Results of a 2-way ANOVA for age a
degree of significance p < 0.05. Significantly higher levels of cytokine at specific timproinflammatory cytokines in the lung, several of the
chemokines showed increased expression with SARS-
CoV infection and were detected at higher levels in the
aged compared to the juvenile host. The T cell chemo-
attractant, CXCL11 was elevated in both age groups with
SARS-CoV infection (Figure 4A). However, CXCL11
levels in the aged lung did not reach the same magni-
tude as the juveniles and were significantly lower in
comparison at 10 d.p.i. (unpaired student T-test). In con-
trast, CCL5, another activated T cell chemoattractant
was significantly higher in aged compared to juvenilected aged and juvenile monkeys
tration pg/ml cytokine +/− SE
Day 5 Day 10 Statistics
Aged Juvenile Aged
16.9 + 3.7 7.1 ± 3.9 6.7 ± 2.1 age p = 0.06
.8 204.6 ± 98.5 151.1 ± 130.2 105.1 ± 73.7
6 45.0 ± 21.2 24.4 ± 8.8 75.9 ± 42.1
3.8 ± 1.2 4.0 ± 1.3 3.2 ± 0.4 d.p.i.*
6 45.0 ± 21.2 24.4 ± 8.8 75.9 ± 42.1
2.7 ± 0.8 2.5 ± 1.1 3.8 ± 2.6
9.9 1920.4 ± 535.5 1826.0 ± 5972 1160.0 ± 415.0 d.p.i.*
4.9 ± 2.9 0.5 ± 0.2 6.6 ± 2.1* age*, d.p.i.*
nd days post infection (d.p.i.) are indicated at the right with asterisks denoting
e points as determined by Bonferonni post tests are in bold.
Figure 3 SARS-CoV induced proinflammatory and antiviral cytokine expression differs in the lungs of aged compared to juvenile
monkeys. Cytokines were measured in standardized-collected lung tissue homogenates from the right caudal lung lobe of both age groups by
bead-based arrays in mock and SARS-CoV infected animals at 5 and 10 days post infection (d.p.i.). Levels of proinflammatory cytokines IL-1Beta
(A) and IL-6 (B) as well as antiviral cytokines IL-12 (C), IL-15 (D), IL-18 (E), and IL-21 (F) were compared in aged and juvenile monkeys. Graphs
represent average values (+/−SE) of cytokine in picograms per milliliter. *p < 0.05 in unpaired student T-test comparing juvenile and aged animals
at the time points indicated by the horizontal bar.
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(Figure 4B; unpaired student T-test). The B cell chemo-
attractant, CXCL13 was dramatically lower in aged as
compared to juvenile animals, regardless of infection sta-
tus whereas CXCL12 and CCL20, known dendritic cell
(DC) chemoattractants, were much higher in mock and
SARS-CoV infected aged animals (Figure 4D-F; unpaired
student T-test).
Inflammatory lung infiltrates in SARS-CoV infection differ
in aged compared to juvenile monkeys
To determine if age impacted the kinetics and magni-
tude of mucosal inflammation in response to SARS-
CoV, immune cell populations were quantified and char-
acterized by flow cytometry in standardized collected
lung tissue (proximal portion of the right caudal lobe)
and lung draining lymph nodes. The number of totallung leukocytes per gram lung tissue was similar at 5 d.
p.i. but was significantly lower in the aged as compared
to juvenile animals at 10 d.p.i. (Figure 5A; unpaired stu-
dent T-test). The frequency of distinct lung leukocyte
populations, including macrophages (CD68 + HLADR+),
dendritic cells (DCs; CD68-HLADR + CD11c+), CD8 T
lymphocytes (CD3 + CD8+), and B cells (CD3-CD20+)
differed in the two age groups during SARS-CoV infec-
tion (Figure 5B-E). Gating strategies are shown in
Additional file 1: Figures S1 and Additional file 2:
Figure S2 and average values are summarized in
Additional file 3: Table S1. The frequency of lung mac-
rophages was lower in aged as compared to juvenile ani-
mals in mock and SARS-CoV infection, reaching
significance at 10 d.p.i. (Figure 5B; unpaired student
T-test). The proportion of lung DCs was also signifi-
cantly lower in aged animals at all infection time points
Figure 4 Aged and juvenile monkeys show distinct lung chemokine profiles during SARS-CoV infection. Chemokines CXCL11 (A), CCL5
(B), IL-8 (C), CXCL13 (D), CXCL12 (E), CCL20 (F) were measured in standardized collected lung tissue homogenates of the right caudal lung lobe
by bead-based arrays as in Figure 3. Graphs represent average values of chemokine in picograms per milliliter (+/−SE). *p < 0.05 for comparison of
age and + p < 0.05 for comparion of time post infection in unpaired student T-test.
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lung B cell frequencies were increased with infection in
juvenile animals, no increase was observed in aged mon-
keys and, at most infection time points, significantly
lower CD8 T cell and B cell frequencies were detected in
aged monkeys (Figure 5D-E; unpaired student T-test). In
contrast to the lung, no age-dependent differences in the
leukocyte numbers or frequency of T and B cells
were noted in the tracheobronchial lymph nodes
(Figure 5F-H; unpaired student T-test).
To further assess the age-specific differences in im-
munity to SARS-CoV infection, the activation status and
chemokine receptor profile was assessed on monocytes/
macrophages, DCs and CD8 T cells. Peripheral mono-
cytes were defined by flow cytometry using CD14 and
HLADR expression and DCs as CD14-HLADR+CD11c +
(see peripheral blood monocyte and DC gating strategy
in Additional file 4: Figure S3). Expression of the activa-
tion marker CD86 showed significant age-dependent dif-
ferences in the monocytes, lung macrophages and DCpopulations with significantly less expression in aged
SARS-CoV-infected animals (Table 3; 2-way ANOVA;
Additional file 2: Figures S2 and Additional file 4: Figure
S3). We also examined peripheral monocytes, DCs and
CD8 T cells for CCL5 and CCL20 receptor expression as
these chemokines were found at highest concentrations in
the aged lung. For CCL5 receptors, aged monocytes
showed reduced CCR3 but similar levels of CCR1 com-
pared to their juvenile counterparts (Table 3, 2-way
ANOVA for age and d.p.i.). The frequency of CD8 T
cells expressing CCR5 (another CCL5 receptor) was not
significantly impacted by age. The receptor for CCL20,
CCR6 was significantly down regulated with age and
SARS-CoV infection on peripheral blood DCs (Table 3,
2-way ANOVA for age and d.p.i.).
Impact of age on SARS-CoV specific T and B cell
responses
CD8 T cell responses to SARS-CoV infection were eval-
uated in peripheral blood, lung and tracheobronchial
Figure 5 Age-specific differences in leukocyte populations in the lung but not lymph node following SARS-CoV infection. (A) The
number of total lung leukocytes was calculated per gram of tissue in standardized collected samples from mock- and SARS-CoV infected animals
at 5 and 10 days post infection (d.p.i.). Samples were taken from the proximal portion of the right caudal lobe adjacent to the region used for
cytokine analysis (Figures 3–4). Flow cytometry was used to further characterize the major leukocyte populations in the lung mucosa. The percent
frequency of total lung leukocytes are indicated for (B) macrophages (CD68 + HLADR+), (C) dendritic cells (DCs; CD68-HLADR + CD11c+), (D) CD8
T lymphocytes (CD3 + CD8+) and (E) B cells (CD3-CD20+). (F) The number of total cells collected from the tracheobronchial lymph node (LN)
tissue was quantitated for mock- and SARS-CoV infected animals at 5 and 10 d.p.i.. The percent frequency of total lymph node cells were
determined for (G) CD8+ T cells and (H) B cells. Graphs represent average values (+/−SE). The gating strategies for flow cytometric analysis are
shown in Additional file 1: Figures S1 and Additional file 2: Figure S2 and percent frequencies summarized in Additional file 3: Table S1. *p < 0.05,
**p < 0.01 in unpaired student T-test comparing age groups. +p < 0.05 for comparing infection time points.
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egy in Additional file 1: Figures S1 and Additional file 2:
Figure S2). Although no age-dependent differences were
observed in the frequency of naïve (CD45RA + CCR7+)
CD8 T cells in peripheral blood, there were significantly
lower levels of these cells in the lung and lymph node of
aged animals during SARS-CoV infection (Figure 6A-C;
unpaired student T-tests). A similar trend was observed
with proliferating and cytotoxic granzyme B + CD8 T
cells which were lower in the lungs and lymph nodes of
aged compared to their juvenile counterparts at most in-
fection time points (Figure 6D-I; unpaired student T-
test). However, granzyme B + T cell levels tended to be
higher in the peripheral blood of aged comparedto juvenile animals, reaching significance at 1 d.p.i.
(Figure 6G; unpaired student T-test). To determine how
the B cell response to SARS-CoV was impacted by age,
anti-SARS-CoV antibodies were evaluated in the serum
and lung. Serum neutralization assays revealed increased
antibodies in all juvenile animals with SARS-CoV infec-
tion as early as 5 d.p.i. (Figure 7A; 2-way ANOVA for
age and d.p.i.). In contrast, SARS-CoV neutralizing anti-
bodies were not detected until 10 d.p.i. in aged monkeys,
with antibody titers that were significantly lower as com-
pared to juveniles. Anti-SARS-CoV IgG and IgA anti-
bodies in lung tissue homogenates were determined by
ELISA. Lung anti-SARS-CoV IgG was detected in 1 aged
and 2 juvenile animals at 5 d.p.i. and although titers
Table 3 Percent frequency of chemokine receptor and activation marker positive leukocytes in SARS-CoV infected aged
and juvenile monkeys
Frequency of cellsa
Peripheral blood Day 1 Day 5 Day 10
Juvenile Aged Juvenile Aged Juvenile Aged Statistics
Monocytes
CCR1 5.0 ± 0.9 1.8 ± 0.4 1.0 ± 0.1 2.2 ± 1.7 2.5 ± 0.3 2.4 ± 0.6 d.p.i*
CCR3 1.6 ± 0.4 1.9 ± 04 1.1 ± 01 2.2 ± 12 1.1 ± 01 2.4 ± 0.6 age*
CD86 8.9 ± 13 3.8 ± 0.4 6.3 ± 2.0 3.9 ± 1.9 4.7 ± 0.3 5.2 ± 1.6 age*
DCs
CCR6 0.6 ± 0.3 0.3 ± 0.2 0.6 ± 0.2 0.0 ± 0.0 0.3 ± 01 0.2 ± 0.0 age**, d.p.i*
CD86 1.4 ± 0.5 0.2 ± 0.0 2.9 ± 0.9 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 age****
CD8 + T cells
CCR5 6.9 ± 1.2 2.5 ± 0.4 1.8 ± 0.3 2.0 ± 0.5 3.7 ± 0.3 9.9 ± 3.4 d.p.i**
Lung Mock Day 5 Day 10
Juvenile Aged Juvenile Aged Juvenile Aged Statistics
Macrophages
CD86 20.5 ± 1.7 2.3 ± 0.1 36.4 ± 4.8 3.1 ± 1.1 34.2 ± 2.1 3.3 ± 1.7 age****
DCs
CD86 1.1 ± 0.3 0.3 ± 0.1 3.7 ± 0.5 0.4 ± 0.1 2.0 ± 0.5 0.3 ± 0.1 age****
aAverage frequency of chemokine receptor or activation marker positive cells of total perhipheral blood or lung leukocytes. Monocytes (CD14 + HLADR+),
peripheral blood dendritic cells (DCs: CD14-HLADR + CD11c+), CD8 T cells (CD3 + CD8+). Lung macrophages are defined as CD68 + HLADR + and lung DCs as
CD68-HLADR + CD11c+. Gating strategies are show in Additional file 1: Figure S1, Additional file 2: Figure S2 and Additional file 4: Figure S3. Statistical results of
2-way ANOVas for age and days post infection (d.p.i.) are indicated at the right with asterisks denoting degree of sigrificance: *p < 0.05, **p < 0.005 ****p < 0.0001.
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anti-SARS CoV IgG titers was observed in aged animals
(Figure 7B, no significance by unpaired student T test).
Anti-SARS-CoV IgA titers were significantly lower in
aged as compared to juvenile animals at 10 d.p.i., with
average titers that were up to 18-fold lower in the aged
host (Figure 7C, unpaired student T test).
Discussion
The elderly (those over 65), are considered the fastest-
growing demographic in the United States and are ex-
pected to make up 19% of the population by 2030 [31].
It is well recognized that elderly individuals incur en-
hanced severity of respiratory infections and according
to the Center for Disease Control and Prevention, an es-
timated 9 out of 10 flu-related deaths in the United
States occur in people 65 and older. When SARS-CoV
emerged in the human population in 2002, the elderly
were also disproportionately affected, with individuals
over 65 making up 50% of the total fatal cases [32,33].
We have a poor understanding of the relationship be-
tween aging and the host response to respiratory virus
infection. Most of our understanding of the biological
changes that occur with aging in humans has been lim-
ited to studies of peripheral blood, which may not reflect
the immune dynamics of the respiratory tract. Our study
aimed at gaining insight into the kinetics and magnitudeof the systemic and mucosal immune response to SARS-
CoV infection in aged nonhuman primates, an import-
ant translational model for immune-aging research.
The significantly higher levels of viral replication in
the nasal secretions of aged monkeys as compared to the
juvenile animals at 1 d.p.i. was unexpected as most aged
SARS-CoV studies have detected no age-dependent dif-
ferences in infection levels. Higher SARS-CoV titers may
have been missed in the previous aged nonhuman pri-
mate experiment as 2 d.p.i. was their earliest sampling
time point, [22] and by day 3 in our study, aged and ju-
venile infection levels were similar. Although we cannot
be certain that we were measuring replicating virus and
not virus delivered from the inoculum, the dramatic dif-
ference in the amount recovered suggests that the aged
nasal epithelium may support higher levels of SARS-
CoV, or that the nasal cavity drainage mechanisms are
impaired in the aged host. Despite the early age-
associated differences in viral shedding at mucosal sites,
by 5 d.p.i., levels of SARS-CoV in respiratory tract tis-
sues were only slightly higher in the aged monkeys.
Similar to previous reports, virus was not recovered
from any animal at 10 d.p.i., suggesting that the kinetics
of viral clearance may have been similar in both age
groups. However, additional sampling between days 5
and 10 post infection would be necessary to confirm this
observation.
Figure 6 Comparison of T lymphocyte responses to SARS-CoV infection in the aged and juvenile monkey. CD8 T cells were evaluated by
flow cytometric analysis for coexpression of naïve cell markers CD45RA and CCR7 (A-C); proliferation marker, Ki67 (D-F); and cytotoxic enzyme,
granzyme B (G-I) in the peripheral blood, lung and tracheobronchial lymph nodes. Graphs represent average values (+/−SE). The gating strategy
for flow cytometric analysis is shown in Additional file 1: Figures S1 and Additional file 2: Figure S2. *p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001 in unpaired student T-tests comparing age groups.
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decreased total white blood cell counts which is consist-
ent with the inverse correlation of WBCs with age that
has been observed at steady state in several rhesus and
human studies [25,34]. Of the leukocyte populations in
the blood, lymphocyte numbers were most dramatically
affected by age, with flow cytometric results showing
significantly reduced CD8 T cells and B cells in aged
compared to juvenile monkeys. In contrast, peripheral
cytokine responses showed only minimal age-related dif-
ferences to SARS-CoV infection which may be related to
the high variability, particularly in the aged group, which
is consistent with previous reports in elderly rhesus
monkeys [5,25]. In regards to the mucosal inflammatory
reactions, proinflammatory cytokines IL-1beta, IL-6, IL-
15, IL-12 and IL-18 were all significantly lower in the
lungs of SARS-CoV-infected aged animals at either day
5 or 10 post infection. In particular, the reduced levels ofIL-1beta and IL-18 are in line with recent reports of im-
paired NLRP3 inflammasome function in elderly mice
during influenza infection [35]. The low cytokine re-
sponse in aged monkeys may also be a reflection of the
reduced total inflammatory cell numbers found in the
lungs of aged as compared to juvenile animals as cells
and cytokines were evaluated in adjacent lung regions.
Our data is not consistent with the exacerbated acute in-
flammatory responses shown to promote disease patho-
genesis in aged SARS-CoV-infected mouse models
[19,21]. As we did not sample earlier than day 5 post in-
fection in the lung, the increased inflammation in our
aged monkeys may have been missed. Our sampling
schedule may have also precluded collections at optimal
inflammatory response time points, as a biphasic pattern
occurring in waves, at day 2 and 7 post infection with
mouse-adapted SARS-CoV strains has been described in
aged rodents [20,36].
Figure 7 Limited systemic and mucosal B cell responses in
aged monkeys infected with SARS-CoV. (A) SARS-CoV neutralizing
antibodies were measured in sera of aged and juvenile animals over
the infection time course. Graphs represent average values (+/−SE).
For day 0, aged n = 10, juvenile n = 12. For day 5 and 10 post
infection n = 5 for aged and n = 6 for juvenile. ****p < 0.0001 for
age and time post infection (d.p.i.) as indicated in the graph by
2-way ANOVA with a Bonferroni post-test, p < 0.05. (B-C) Anti-SARS-
CoV spike protein specific IgG (B) and IgA (C) were measured in
lung tissue homogenates by ELISA. Graphs represent average values,
n = 5 for aged and n = 6 for juvenile (+/−SE). *p < 0.05 in unpaired
student T-test comparing juvenile and aged animals at the time
points indicated by the horizontal bar.
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and those from aged mice, most of our results are also
dissimilar to the previously reported aged nonhumanprimate SARS-CoV study by Smits et al., [22] as we did
not observe stronger innate immune responses or more
severe pathology in our aged monkeys. In comparing
our results, there are several experimental design aspects
to take into consideration, beyond differences in dose
and route of SARS-CoV infection. First, cynomolgous
macaques were used in the previous study whereas our
SARS-CoV infection model utilizes African green mon-
keys. In addition, timing of lung sample collection dif-
fered between the two studies, days 2 and 4 were
assessed in the cynomolgous macaques while days 5,
and 10 post infection were evaluated in our study. Fur-
thermore, a standardized lung collection scheme was
used in our immunology and pathology analysis, to give
a more comprehensive perspective whereas their study
assessed gene changes in specific regions of high SARS-
CoV replication. Despite the major differences in study
design, there were several results that were comparable,
including the similarity of SARS-CoV viral titers in the
aged and juvenile lung at later infection time points
(days 4 and 5). In addition, several chemokines, includ-
ing CCL5, CXCL12 and CCL20 were significantly
increased in the lungs of SARS-CoV-infected aged mon-
keys here, which is consistent with the finding of ele-
vated chemokine signaling genes in the aged lungs of
cynomolgous macaques during SARS-CoV infection by
microarray [22].
Immune senescence has been shown to impact innate as
well as adaptive branches of the immune system, both con-
tributing to the diminished immunity observed in the eld-
erly [24,37]. In examination of the kinetics of lung and
lymph node cell expansion and/or trafficking following
SARS-CoV infection, we found significantly reduced lung
macrophages, DCs, CD8 T cells and B cells in the aged ani-
mals relative to their juvenile counterparts. Not only were
there fewer lung macrophages and DCs in the aged ani-
mals, but the frequency of costimulatory CD86+ cells were
also significantly reduced. In contrast, the lymph node reac-
tion showed no age-specific differences. Interestingly, al-
though lung leukocyte numbers were reduced in aged
monkeys there were disproportionately high levels of the
chemokines capable of recruiting these cells into the lung,
CCL5, CXCL11, CXCL12 and CCL20. This prompted our
examination of the expression of the corresponding ligand-
binding receptors on peripheral blood leukocytes to deter-
mine if there were age-related differences in the migratory
capacity of these cells into the lung. For CCL5 receptors,
we found significantly reduced frequencies of CCR3 but
not CCR1+ monocytes in aged animals and similar fre-
quencies of CCR5+ CD8 T cells in both age groups. The
frequency of aged DCs expressing the CCL20 receptor,
CCR6 showed the most dramatic age-specific reduction
which is reasonable, given that CCR6 is predominantly
expressed by immature DCs and may reflect a reduction of
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lung chemokine and ligand receptor expression may reflect
age-specific modulation of leukocyte trafficking into the
lung. Although we did not confirm these observations with
mechanistic in vitro experiments, previous studies have
shown that DCs acquired from older individuals display sig-
nificantly impaired ability to migrate in response to chemo-
kines [38].
We also examined age-specific differences in both T
and B cell responses to SARS-CoV infection systemic-
ally and at mucosal sites. Not surprisingly, the pro-
portion of naïve CD8 T cells in the lung and lymph
node was significantly reduced in aged compared to
juvenile animals in SARS-CoV infection. This corre-
sponded to significantly lower levels of CD8 T cell
proliferation at these sites in aged animals as well.
Interestingly, the frequency of cytotoxic enzyme posi-
tive (granzyme B) T cells was higher at 1 d.p.i. in the
periphery of aged compared to juvenile animals.
However, aged peripheral granzyme + T cell frequen-
cies remained unchanged by SARS-CoV infection
whereas juvenile cytotoxic T cells showed infection-
induced fluctuation. In contrast to peripheral blood,
the lung and lymph node of aged animals had lower
frequencies of granzyme + T cells compared to juven-
ile animals at 5 and 10 d.p.i.. The humoral response
was also greatly reduced in aged SARS-CoV-infected
monkeys with significantly reduced serum neutralizing
antibodies and mucosal anti-SARS-CoV IgA in the
aged host. This limited antibody response may be re-
lated to the dramatically reduced lung and peripheral
B lymphocyte populations observed in the aged mon-
keys which is consistent with reports in elderly
humans [39]. Despite the deficiencies observed in the
aged adaptive responses, viral titers were only signifi-
cantly higher in aged monkeys at day 1 post infection.
This suggests that innate or other compensatory im-
mune responses are sufficient for viral control in aged
monkeys and serves to further support the minimal
involvement of cytotoxic T cells and neutralizing anti-
bodies in SARS-CoV clearance as demonstrated in
mouse depletion models [36].
Taken together, our data indicate that systemic and
mucosal immunity to SARS-CoV infection differs in
the aged as compared to the juvenile host. This know-
ledge will be important to consider in the design of
effective intervention strategies for SARS-CoV and po-
tentially other respiratory infections. Our experimental
results support future mechanistic studies to identify
adjunctive strategies capable of overcoming the im-
mune deficits of the aged airway mucosa, which may
ultimately translate into novel approaches to enhance
efficacy of vaccines against respiratory pathogens for
the elderly population.Conclusions
In this study we found that viral titers in aged, as com-
pared to juvenile monkeys were significantly higher early
after infection, but levels became comparable in both
age groups at later infection time points. We observed
significant age and infection-dependent differences in
both the systemic and mucosal immune compartments
with more dramatic changes in cytokine levels and
leukocyte frequencies in lung as compared to peripheral
blood and tracheobronchial lymph nodes. In regards to
the exacerbated SARS-CoV responses previously re-
ported in aged nonhuman primates, we did not observe
enhanced host immunity or pathology in our aged mon-
keys. Instead, we detected less inflammatory cytokines
and total lung leukocytes, as well as reduced adaptive re-
sponses with increased age. Although our results are dis-
crepant, both studies indicate that pulmonary immunity
is intrinsically different in the aged as compared to the
juvenile host, warranting further exploration given the
important implications this has for vaccine and thera-
peutic design for the elderly.
Methods
Ethics statement
All procedures were conducted under protocols approved
by the Institutional Animal Care and Use Committee
(IACUC) at Lovelace Respiratory Research Institute (LRRI),
all facilities were accredited by the Association for Assess-
ment and Accreditation of Laboratory Animal Care Inter-
national (AAALAC), and guidelines for nonhuman
primates described in the Guide for the Care and Use of
Laboratory Animals, National Research Council, were
strictly adhered to.
Nonhuman primates
The animals used in this study were adult African green
monkeys obtained from the Barbados Primate Research
Centre, Barbados, West Indies through Global Research
Supply, LLC (Reno, NV), a Class B USDA licensed animal
dealer. A permit to import the animals into New Mexico
was acquired through the Fish and Wildlife Service by
LRRI. The aged African green monkeys were determined to
be ~10-20 yrs old while the remaining subjects were young
adults (~2-6 years old). Additionally, two female African
green monkeys of 17 yrs and 18 yrs were acquired from the
Wake Forest University Primate Center (Medical Center
Boulevard, Winston-Salem). As there is an estimated 3.2-
fold difference for relating age between humans and rhesus
macaques [26,27], the aged African green monkeys in our
study are expected to represent approximately, 50 year old
humans while the juvenile African green monkeys corres-
pond to 6–12 year olds. The rhesus-to-human age conver-
sion was used given that the estimated age conversion is
not as well established for African green monkeys and there
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monkey species belonging to the Super Family Cercopithe-
coidea. Randomization and group assignments for the aged
monkey studies were performed with Provantis Integrated
Preclinical Software (Instem Life Science Systems Ltd.). All
monkeys were quarantined for 6 weeks prior to the study,
during which they were tested for tuberculosis. Animals
were given a subcutaneous microchip for identification
and temperature measurements (IPTT-300 implantable
temperature transponder and a WRS-6007 Handheld
Wireless Reader System (Bio Medic Data Systems, Inc, Sea-
ford, Delaware)). During the infectious portion of the study,
animals were individually housed indoors in stainless steel
cages with wire mesh bottoms. Temperature and humidity
ranges were controlled along with 12 h light and dark cy-
cles. Animals were also given environmental enrichment in-
cluding toys twice per day. Tap water from the institutional
watering system was available ad libitum and animals were
fed twice a day Harlan Teklad Certified 20% Monkey Diet
(4 to 6 biscuits/kg body weight) with bananas or apples for
enrichment 3 times per week.
SARS-CoV infection of African green monkeys
The SARS-CoV strain HKU-39849 was provided by Dr.
Leo Poon (Department of Microbiology, University of
Hong Kong, Hong Kong, China) and viral stocks were
generated in Vero E6 cells. Experimental infection with
107 plaque-forming units (PFU) of SARS-CoV instilled
intranasally was conducted as previously reported [28].
Monkeys were examined by trained Laboratory Animal
Technicians twice per day (at least 6 h apart) on each
day of the study for parameters including appetite, ap-
pearance, activity, stool, posture, neurological signs, res-
piration, ocular discharge and nasal discharge. Onset of
any abnormal clinical sign was documented and a score
sheet completed each day beginning from the date the
animal fell ill. Euthanasia to alleviate suffering was con-
ducted based on the clinical observation score sheet and
consultation with the Staff Veterinarian. Animals were
sacrificed at 5 and 10 d.p.i. (n = 6 for juvenile and n = 5
for aged animals at each time point) by intravenous
overdose of Euthasol® (Virbac AH, Inc., Fort Worth,
TX). Virus-free cell culture medium was used to inocu-
late mock-infected controls (n = 6 for juveniles and n = 2
for aged). Some of the immunology, virology and path-
ology data for the juvenile animals were previously re-
ported [28] but are included in this manuscript for
comparison with aged monkeys.
Plaque and neutralization assays
Virus titers were measured in plaque assays by applying
serial dilutions of homogenized tissue supernatants onto
Vero E6 cell monolayers as previously described [28]. To
measure SARS-CoV neutralizing antibodies in serum,samples were serially diluted and incubated with 2,000
PFU/ml SARS-CoV overnight before inoculation onto
Vero E6 cells. Titers are expressed as the reciprocal of
the highest dilution at which the cytopathic effect was
completely inhibited.
Flow cytometry
Standardized collected lung tissue from the proximal
portion of the right caudal lobe was processed into
single-cell suspensions for flow cytometry. Of note, the
samples for flow cytometric analysis and cytokine pro-
tein evaluation were acquired from adjacent tissue re-
gions. Single cell suspensions were prepared as detailed
in [28]. Briefly, mechanical and enzymatic digestion with
Liberase (Roche, Pleasanton, CA) and DNAse (Sigma,
St. Louis, MO) solution was performed prior to overlay-
ing samples on a Percoll (Sigma) gradient for 20 min at
500 × g with no brake. Tracheobronchial lymph nodes
were collected in a standardized manner in which the
same region and size of tissue was collected from each
animal. Single-cell suspensions were made by mechan-
ical disruption. Peripheral blood mononuclear cells
(PBMC) were isolated from heparinized blood with a
Ficol-Hypaque (Sigma) gradient as previously reported
[41]. All flow cytometric analysis was conducted on pre-
viously frozen PBMC, lung or lymph node leukocytes.
The following antibodies were used in 4- or 6- color
staining panels: CD3 (clone SDP34-2); CD8 (clone SK1);
CD11c (clone SHCL-3); CD14 (clone M5E2); CD20
(clone L27); CD68 (clone KP1, Santa Cruz Biotechnolo-
gies, Dallas, TX); CD86 (clone 2331Fun1); Granzyme B
(clone GB11, Invitrogen, Carlsbad CA); HLA-DR (clone
L243); Ki67 (clone B56); CCR1 (clone 53504); CCR3
(clone 61828); CCR5 (clone 3A9); CCR6 (clone 11A9)
and CCR7 (clone 150503, R&D Systems, Minneapolis,
MN) all conjugated to fluorochromes FITC, PE, PerCP,
PerCpCy5.5, APC, PECy7, Alexa647 or APCCy7 (BD
Biosciences, San Jose, CA unless specified). For intracel-
lular antigens, BD FACS lyse and permeabilization solu-
tions were used according to the manufacturer’s
instructions. CD4 was not assessed given the downregu-
lation of this marker on African green monkey T lym-
phocytes [42-44]. Antibody-stained samples were fixed
for 16 hr in 1% paraformaldehyde and 3% FBS in phos-
phate buffered saline. Sample data were acquired on a
FACS-Calibur or FACS-Canto flow cytometer instru-
ment (BD Biosciences) and data files analyzed utilizing
FlowJo software 7.6.1 (TreeStar, Medford, OR). For all
flow cytometric analysis, within one experiment, the
gates applied to each sample were identical (See gating
strategies in Additional file 1: Figure S1, Additional
file 2: Figure S2 and Additional file 4: Figure S3). When
appropriate and possible, similar gates were used across
the two different experiments (juvenile and aged
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settings and fluorescence minus one controls, some
gates were adjusted between the two experiments.
Markers were chosen for characterization of specific
leukocyte subsets in PBMC, lymph node, and lung based
on previously published studies in humans or nonhuman
primates [45-53].ELISAS and cytokine bead-based assays
Lung tissue was acquired in a standardized collection
scheme in which a section of the proximal right caudal lobe
was divided into two portions, one for homogenization to
assess cytokines and antibodies and virus while lung leuko-
cytes were isolated from the other portion for flow cytome-
try (see previous section). For homogenization, a volume of
RPMI media (Gibco, Life Techologies, Grand Island, NY)
equal to 10% of the lung tissue weight was added. SARS-
CoV IgG and IgA antibodies were measured by ELISA
detailed in [28]. Briefly, ELISA plates were coated with
purified recombinant SARS-CoV S protein in carbonate-
coating buffer (S protein NR-686 obtained through NIH
Biodefense and Emerging Infections Research Resources
Repository) and nonspecific binding blocked with Power-
Block (Biogenex, San Ramon CA). Starting at a 1:25 dilu-
tion, serially diluted lung tissue homogenate supernatants
(clarified by centrifugation) were incubated on S-protein
coated plates overnight at 37°C. An anti-monkey IgG or
IgA HRP-conjugated antibody (KPL Inc., Gaithersburg,
MD) was applied followed by substrate development with
ABTS Microwell peroxidase substrate system (KPL) and
absorbance reading at 405 nm using a Thermo Electron
Corporation plate reader (Thermo Electron Corporation,
Houston, TX). Data was acquired with Ascent software
(Ascent Software, London, UK) and the ELISA antibody
titer recorded for each sample was the reciprocal of the
highest dilution in which the optical density (O.D.) reading
for S-protein bound wells was at least two-fold higher than
that of the nonfat milk control. The O.D. of the highest titer
chosen also had to fall within the linear range of the serial
dilutions.
Cytokine and chemokine protein was measured in
lung tissue homogenates and serum using both human
and nonhuman primate multiplex bead-based array kits
(Millipore, Billerica, MA). The assays were performed
according to the manufacturer’s instructions with an
overnight incubation of the samples in antibody-
immobilized beads. Data was collected on the Bio-Plex
System (BioRad, Hercules, CA) and a weighted 5-
parameter logistic curve-fitting method used to calculate
the concentration of individual analytes. All measure-
ments were performed in duplicate and data reported as
pg/ml. CD40L was undetectable in serum of either age
group and IL-5, TNF-alpha, IL-17, IL-2, CCL24 andCCL26 were below the level of detection in lung tissue
homogenates.
Histopathology
Sampling of tissues for histopathology was performed as
previously reported [28] in a standardized manner with
random assessment. All organs were fixed in 4% parafor-
maldehyde solution prior to embedding in paraffin.
5 μm thick tissue sections were stained with hematoxylin
and eosin for examination microscopically by a board
certified veterinary pathologist. Histologic lesions were
graded for severity (0 = normal, 1 =minimal, 2 =mild,
3 =moderate, 4 =marked) and distribution, (focal, multi-
focal, diffuse).
Statistical analysis
Infection and age differences were evaluated using a 2-
way ANOVA with Bonferroni post-tests or two-tailed
student T-tests, where appropriate. All data for statistical
evaluation was log transformed and analyzed with
GraphPad Prism 5.0 software (GraphPad, La Jolla, CA).
A p value of 0.05 or less was considered statistically
significant.
Additional files
Additional file 1: Figure S1. Gating strategy for analysis of extracellular
markers on B and T cells. The representative gating strategy for flow
cytometric analysis of lung, lymph node and PBMC is illustrated based on
PBMC from an aged monkey. First a lymphocyte gate based on forward
and side scatter is applied with the percent frequency of total cells
indicated in the plot (FSC/SSC). CD8 T cells were subsequently gated
based on CD3 and CD8 expression (CD3 + CD8+). CD8 T cells were
further evaluated for coexpression of naïve cell markers CCR7 and
CD45RA (CCR7 + CD45RA+) or CCR5 expression. B lymphocytes were
gated based on CD20 expression and absence of CD3 (CD3-CD20+). The
percent frequencies of total gated lymphocytes based on the FSC/SSC
gate are indicated in each plot.
Additional file 2: Figure S2. Gating strategy for analysis of intracellular
markers. The gating strategy for flow cytometric analysis of macrophages,
dendritic cells and CD8 T cells in which intracellular markers were used is
shown using a representative lung sample from an aged animal.
Leukocytes were first gated on forward and side scatter with the percent
frequency of total cells indicated in the plot (FSC/SSC). Cells were
subsequently gated on CD68 and HLADR for macrophages and dendritic
cells (DCs) (CD68/HLADR). Macrophages were defined as CD68 + HLADR +
and were evaluated for expression of CD86. CD68 negative HLADR + cells
were further gated on CD11c positive to define DCs (CD68-HLADR + CD11c+)
which were also evaluated for CD86 expression. CD8 T cells were defined as
CD3 + CD8+ and were assessed for expression of intracellular antigens, Ki67
and granzyme B. The percent frequencies of total gated leukocytes based on
FSC/SSC are indicated in each plot.
Additional file 3: Table S1. Relative frequency of leukocyte populations
in the lung and lymph node during SARS-CoV infection.
Additional file 4: Figure S3. Gating strategy for peripheral monocytes
and dendritic cells. The gating strategy for monocytes and DCs in the
peripheral blood is depicted using a representative aged PBMC sample.
Cells are first gated based on forward and side scatter with the percent
frequency of total cells indicated in the plot. The subsequent gate is for
CD14 and HLADR expression in which monocytes are defined as CD14 +
HLADR+. Monocytes are subsequently evaluated for CD86, CCR1 and
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CD11c expression to define DCs (CD14-HLADR + CD11c+). CD86 and
CCR6 expression was then evaluated on DCs. The percent frequencies of
total gated leukocytes based on FSC/SSC are indicated in each plot.
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